As of 2026-03-27, the Relative Valuation of Atara Biotherapeutics Inc (ATRA) is 76.11 USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.71 USD, the upside of Atara Biotherapeutics Inc based on Relative Valuation is 1515.9%.
The range of the Relative Valuation is 67.38 - 91.85 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 28.3x | 24.7x |
| Forward P/E multiples | 20.8x - 27.0x | 22.2x |
| Fair Price | 67.38 - 91.85 | 76.11 |
| Upside | 1330.6% - 1850.1% | 1515.9% |
| Date | P/E |
| 2026-03-20 | 1.51 |
| 2026-03-19 | 1.58 |
| 2026-03-18 | 1.54 |
| 2026-03-17 | 1.61 |
| 2026-03-16 | 1.81 |
| 2026-03-13 | 2.00 |
| 2026-03-12 | 2.13 |
| 2026-03-11 | 1.92 |
| 2026-03-10 | 1.94 |
| 2026-03-09 | 2.06 |
| 2026-03-06 | 1.59 |
| 2026-03-05 | 1.54 |
| 2026-03-04 | 1.66 |
| 2026-03-03 | 1.67 |
| 2026-03-02 | 1.51 |
| 2026-02-27 | 1.67 |
| 2026-02-26 | 1.62 |
| 2026-02-25 | 1.56 |
| 2026-02-24 | 1.30 |
| 2026-02-23 | 1.29 |
| 2026-02-20 | 1.29 |
| 2026-02-19 | 1.31 |
| 2026-02-18 | 1.36 |
| 2026-02-17 | 1.38 |
| 2026-02-13 | 1.37 |
| 2026-02-12 | 1.37 |
| 2026-02-11 | 1.41 |
| 2026-02-10 | 1.49 |
| 2026-02-09 | 1.53 |
| 2026-02-06 | 1.50 |
| 2026-02-05 | 1.39 |
| 2026-02-04 | 1.50 |
| 2026-02-03 | 1.55 |
| 2026-02-02 | 1.55 |
| 2026-01-30 | 1.60 |
| 2026-01-29 | 1.70 |
| 2026-01-28 | 1.69 |
| 2026-01-27 | 1.71 |
| 2026-01-26 | 1.63 |
| 2026-01-23 | 1.61 |
| 2026-01-22 | 1.54 |
| 2026-01-21 | 1.42 |
| 2026-01-20 | 1.33 |
| 2026-01-16 | 1.40 |
| 2026-01-15 | 1.42 |
| 2026-01-14 | 1.38 |
| 2026-01-13 | 1.35 |
| 2026-01-12 | 1.81 |
| 2026-01-09 | 4.21 |
| 2026-01-08 | 5.37 |